{"pmid":32409503,"title":"The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic.","text":["The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic.","Diabetes Care","McIntyre, H David","Moses, Robert G","32409503"],"journal":"Diabetes Care","authors":["McIntyre, H David","Moses, Robert G"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409503","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.2337/dci20-0026","topics":["Prevention"],"weight":1,"_version_":1666897319061094402,"score":9.490897,"similar":[{"pmid":32454456,"title":"Endocrinology in the time of COVID-19: Diagnosis and Management of Gestational Diabetes Mellitus.","text":["Endocrinology in the time of COVID-19: Diagnosis and Management of Gestational Diabetes Mellitus.","The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometimes competing requirement of lowering the risk of direct viral transmission against the potential adverse impact of service changes. We suggest pragmatic options for screening of GDM in a pandemic setting based on blood tests, and risk calculators applied to underlying risk factors. Alternative models for antenatal care provision for women with GDM, including targeting high-risk groups, early lifestyle interventions and remote monitoring are provided. Testing options and their timing for postpartum screening in women who had GDM are also considered. Our suggestions are only applicable in a pandemic scenario; usual guidelines and care pathways should be re-implemented as soon as possible and appropriate.","Eur J Endocrinol","Thangaratinam, Shakila","Cooray, Shamil D","Sukumar, Nithya","Huda, Mohammed S","Devlieger, Roland","Benhalima, Katrien","McAuliffe, Fionnuala","Saravanan, Ponnusamy","Teede, Helena","32454456"],"abstract":["The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometimes competing requirement of lowering the risk of direct viral transmission against the potential adverse impact of service changes. We suggest pragmatic options for screening of GDM in a pandemic setting based on blood tests, and risk calculators applied to underlying risk factors. Alternative models for antenatal care provision for women with GDM, including targeting high-risk groups, early lifestyle interventions and remote monitoring are provided. Testing options and their timing for postpartum screening in women who had GDM are also considered. Our suggestions are only applicable in a pandemic scenario; usual guidelines and care pathways should be re-implemented as soon as possible and appropriate."],"journal":"Eur J Endocrinol","authors":["Thangaratinam, Shakila","Cooray, Shamil D","Sukumar, Nithya","Huda, Mohammed S","Devlieger, Roland","Benhalima, Katrien","McAuliffe, Fionnuala","Saravanan, Ponnusamy","Teede, Helena"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454456","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1530/EJE-20-0401","topics":["Prevention"],"weight":1,"_version_":1667881798544130049,"score":81.76373},{"pmid":32488991,"title":"Managing Type 2 Diabetes Mellitus during COVID-19 Pandemic: The Bittersweet.","text":["Managing Type 2 Diabetes Mellitus during COVID-19 Pandemic: The Bittersweet.","Diabetes Metab Res Rev","Yehya, Amin","Carbone, Salvatore","32488991"],"journal":"Diabetes Metab Res Rev","authors":["Yehya, Amin","Carbone, Salvatore"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32488991","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/dmrr.3360","topics":["Prevention"],"weight":1,"_version_":1668623433557082112,"score":60.889347},{"pmid":32339533,"pmcid":"PMC7194589","title":"Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus.","text":["Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus.","Diabetes Res Clin Pract","Jie Chee, Ying","Jia Huey Ng, Shereen","Yeoh, Ester","32339533"],"journal":"Diabetes Res Clin Pract","authors":["Jie Chee, Ying","Jia Huey Ng, Shereen","Yeoh, Ester"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339533","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.diabres.2020.108166","topics":["Case Report"],"weight":1,"_version_":1666138494240555008,"score":57.550888},{"pmid":32425483,"pmcid":"PMC7233205","title":"Diabetes mellitus: Lessons from the COVID-19 pandemic.","text":["Diabetes mellitus: Lessons from the COVID-19 pandemic.","Hellenic J Cardiol","Tousoulis, Dimitris","32425483"],"journal":"Hellenic J Cardiol","authors":["Tousoulis, Dimitris"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425483","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.hjc.2020.03.009","topics":["Prevention"],"weight":1,"_version_":1667252837911887873,"score":56.498657},{"pmid":32228322,"title":"COVID-19 pandemic, coronaviruses, and diabetes mellitus.","text":["COVID-19 pandemic, coronaviruses, and diabetes mellitus.","The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension, and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on SARS-CoV-2, Middle East respiratory syndrome (MERS-CoV), and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes.","Am J Physiol Endocrinol Metab","Muniyappa, Ranganath","Gubbi, Sriram","32228322"],"abstract":["The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension, and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on SARS-CoV-2, Middle East respiratory syndrome (MERS-CoV), and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes."],"journal":"Am J Physiol Endocrinol Metab","authors":["Muniyappa, Ranganath","Gubbi, Sriram"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32228322","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1152/ajpendo.00124.2020","keywords":["covid-19","coronavirus","diabetes mellitus"],"topics":["Mechanism"],"weight":1,"_version_":1666138492176957440,"score":53.57974}]}